Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review.
Biomedicines
; 9(12)2021 Dec 10.
Article
in En
| MEDLINE
| ID: mdl-34944686
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Biomedicines
Year:
2021
Document type:
Article
Affiliation country:
Italy
Country of publication:
Switzerland